共 50 条
- [21] YAP/TAZ-TEAD is a novel transcriptional regulator of genes encoding steroidogenic enzymes in rat granulosa cells and KGN cellsMOLECULAR AND CELLULAR ENDOCRINOLOGY, 2023, 559论文数: 引用数: h-index:机构:Orisaka, Makoto论文数: 0 引用数: 0 h-index: 0机构: Univ Fukui, Fac Med Sci, Dept Obstet & Gynecol, Fukui, Japan Fukui Prefectural Univ, Fac Nursing & Welf Sci, Dept Nursing, 4-1-1 Kenjojima, Fukui 9101195, JapanKawabe, Shinya论文数: 0 引用数: 0 h-index: 0机构: Natl Fisheries Univ, Dept Food Sci & Technol, Shimonoseki, Yamaguchi, Japan Fukui Prefectural Univ, Fac Nursing & Welf Sci, Dept Nursing, 4-1-1 Kenjojima, Fukui 9101195, JapanMorichika, Ririko论文数: 0 引用数: 0 h-index: 0机构: Fukui Prefectural Univ, Fac Nursing & Welf Sci, Dept Nursing, 4-1-1 Kenjojima, Fukui 9101195, Japan Fukui Prefectural Univ, Fac Nursing & Welf Sci, Dept Nursing, 4-1-1 Kenjojima, Fukui 9101195, JapanUesaka, Miki论文数: 0 引用数: 0 h-index: 0机构: Univ Fukui, Fac Med Sci, Dept Obstet & Gynecol, Fukui, Japan Fukui Prefectural Univ, Fac Nursing & Welf Sci, Dept Nursing, 4-1-1 Kenjojima, Fukui 9101195, JapanYoshida, Yoshio论文数: 0 引用数: 0 h-index: 0机构: Univ Fukui, Fac Med Sci, Dept Obstet & Gynecol, Fukui, Japan Fukui Prefectural Univ, Fac Nursing & Welf Sci, Dept Nursing, 4-1-1 Kenjojima, Fukui 9101195, Japan
- [22] Activation of Hepatocyte Growth Factor/MET Signaling as a Mechanism of Acquired Resistance to a Novel YAP1/TEAD Small Molecule InhibitorMOLECULAR CANCER THERAPEUTICS, 2024, 23 (08) : 1095 - 1108Moure, Casey J.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USA Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USAVara, Brandon论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Discovery Chem, Rahway, NJ USA Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USACheng, Mangeng M.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USA Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USASondey, Christopher论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USA Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USAMuise, Eric论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Data & Genome Sci, Rahway, NJ USA Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USAPark, Eunsil论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USA Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USAVela Ramirez, Julia Eulalia论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Discovery Pharmaceut Sci, Rahway, NJ USA Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USASu, Dan论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USA Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USAD'Souza, Shanti论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Discovery Oncol, Rahway, NJ USA Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USAYan, Qingyun论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USA Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USAYeung, Charles S.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Discovery Chem, Rahway, NJ USA Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USAZhang, Minjia论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USA Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USAMansueto, My Sam论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USA Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USALinn, Doug论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USA Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USABuchanan, Mark论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USA Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USAFoti, Robert论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept PPDM, Rahway, NJ USA Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USADimauro, Erin论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Discovery Chem, Rahway, NJ USA Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USALong, Brian论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USA Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USASimov, Vladimir论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Discovery Chem, Rahway, NJ USA Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USABarry, Evan R.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USA Merck & Co Inc, Dept Quantitat Biosci, Rahway, NJ USA
- [23] Identification and target deconvolution of novel small molecule inhibitors of oncogenic YAP1/TAZ activityEUROPEAN JOURNAL OF CANCER, 2024, 211 : S157 - S157Lange, M.论文数: 0 引用数: 0 h-index: 0机构: Nuvisan ICB GmbH, Therapeut Res, Berlin, Germany Nuvisan ICB GmbH, Therapeut Res, Berlin, GermanyNicke, B.论文数: 0 引用数: 0 h-index: 0机构: Nuvisan ICB GmbH, Therapeut Res, Berlin, Germany Nuvisan ICB GmbH, Therapeut Res, Berlin, GermanyNaujoks, J.论文数: 0 引用数: 0 h-index: 0机构: Nuvisan ICB GmbH, Therapeut Res, Berlin, Germany Nuvisan ICB GmbH, Therapeut Res, Berlin, Germany
- [24] Antitumor activity of novel and potent YAP/TAZ-TEAD inhibitorstargeting the Hippo pathway in solid tumorsCANCER RESEARCH, 2023, 83 (07)Kim, Jisook论文数: 0 引用数: 0 h-index: 0Jung, Seung Hyun论文数: 0 引用数: 0 h-index: 0Han, Seon Yeong论文数: 0 引用数: 0 h-index: 0Yoon, Jihee论文数: 0 引用数: 0 h-index: 0Kim, Minjeong论文数: 0 引用数: 0 h-index: 0Byun, Jooyun论文数: 0 引用数: 0 h-index: 0Moon, Heesun论文数: 0 引用数: 0 h-index: 0Lee, Eunyoung论文数: 0 引用数: 0 h-index: 0Kim, Yu-Yon论文数: 0 引用数: 0 h-index: 0Park, Hyunjin论文数: 0 引用数: 0 h-index: 0Jeon, Ye论文数: 0 引用数: 0 h-index: 0Ahn, Young Gil论文数: 0 引用数: 0 h-index: 0Kim, Young Hoon论文数: 0 引用数: 0 h-index: 0Suh, Kwee Hyun论文数: 0 引用数: 0 h-index: 0
- [25] Discovery of novel potent allosteric inhibitors of YAP/TAZ-TEAD transcription for the treatment of multiple solid tumor types addicted to Hippo signalingCANCER RESEARCH, 2020, 80 (16)Versele, Matthias论文数: 0 引用数: 0 h-index: 0机构: Ctr Drug Design & Discovery CD3, Leuven, Belgium Ctr Drug Design & Discovery CD3, Leuven, BelgiumCandi, Aurelie论文数: 0 引用数: 0 h-index: 0机构: Ctr Drug Design & Discovery CD3, Leuven, Belgium Ctr Drug Design & Discovery CD3, Leuven, BelgiumNijs, Marnik论文数: 0 引用数: 0 h-index: 0机构: Ctr Drug Design & Discovery CD3, Leuven, Belgium Ctr Drug Design & Discovery CD3, Leuven, BelgiumHaeck, Wanda论文数: 0 引用数: 0 h-index: 0机构: Ctr Drug Design & Discovery CD3, Leuven, Belgium Ctr Drug Design & Discovery CD3, Leuven, BelgiumKlaassen, Hugo论文数: 0 引用数: 0 h-index: 0机构: Ctr Drug Design & Discovery CD3, Leuven, Belgium Ctr Drug Design & Discovery CD3, Leuven, BelgiumSmets, Wim论文数: 0 引用数: 0 h-index: 0机构: Ctr Drug Design & Discovery CD3, Leuven, Belgium Ctr Drug Design & Discovery CD3, Leuven, BelgiumSpieser, Stephane论文数: 0 引用数: 0 h-index: 0机构: Ctr Drug Design & Discovery CD3, Leuven, Belgium Ctr Drug Design & Discovery CD3, Leuven, BelgiumVanderhoydonck, Bart论文数: 0 引用数: 0 h-index: 0机构: Ctr Drug Design & Discovery CD3, Leuven, Belgium Ctr Drug Design & Discovery CD3, Leuven, BelgiumMarchand, Arnaud论文数: 0 引用数: 0 h-index: 0机构: Ctr Drug Design & Discovery CD3, Leuven, Belgium Ctr Drug Design & Discovery CD3, Leuven, BelgiumChaltin, Patrick论文数: 0 引用数: 0 h-index: 0机构: Ctr Drug Design & Discovery CD3, Leuven, Belgium Ctr Drug Design & Discovery CD3, Leuven, BelgiumSansores, Leticia论文数: 0 引用数: 0 h-index: 0机构: VIB Ctr Canc Biol, Leuven, Belgium Ctr Drug Design & Discovery CD3, Leuven, BelgiumHalder, Georg论文数: 0 引用数: 0 h-index: 0机构: VIB Ctr Canc Biol, Leuven, Belgium Ctr Drug Design & Discovery CD3, Leuven, Belgium
- [26] Discovery of ETS-003, a potent and selective YAP/TAZ-TEAD PPI inhibitor with broad anti-tumor activity in Hippo-YAP aberrant cancersCANCER RESEARCH, 2023, 83 (07)Lu, Jiajun论文数: 0 引用数: 0 h-index: 0Gao, Ming论文数: 0 引用数: 0 h-index: 0He, Hao论文数: 0 引用数: 0 h-index: 0Feng, Lijian论文数: 0 引用数: 0 h-index: 0Gao, Zhenting论文数: 0 引用数: 0 h-index: 0Cui, Wenqi论文数: 0 引用数: 0 h-index: 0Yang, Kun论文数: 0 引用数: 0 h-index: 0Lu, Jiting论文数: 0 引用数: 0 h-index: 0Zheng, Qiangang论文数: 0 引用数: 0 h-index: 0Zhu, Jidong论文数: 0 引用数: 0 h-index: 0Guo, Xin论文数: 0 引用数: 0 h-index: 0
- [27] Discovery of a first-in-class TEAD inhibitor which directly inhibits YAP/TAZ-TEAD protein-protein interaction and shows a potent anti-tumor effect in malignant pleural mesotheliomaCANCER RESEARCH, 2019, 79 (13)Kaneda, Ayumi论文数: 0 引用数: 0 h-index: 0机构: Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, Japan Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, JapanSeike, Toshihiro论文数: 0 引用数: 0 h-index: 0机构: Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, Japan Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, JapanUemori, Takeshi论文数: 0 引用数: 0 h-index: 0机构: Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, Japan Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, JapanMyojo, Kensuke论文数: 0 引用数: 0 h-index: 0机构: Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, Japan Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, JapanAida, Kensuke论文数: 0 引用数: 0 h-index: 0机构: Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, Japan Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, JapanDanjo, Tomohiro论文数: 0 引用数: 0 h-index: 0机构: Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, Japan Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, JapanNakajima, Takahiro论文数: 0 引用数: 0 h-index: 0机构: Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, Japan Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, JapanYamaguchi, Daisuke论文数: 0 引用数: 0 h-index: 0机构: Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, Japan Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, JapanHamada, Tomoko论文数: 0 引用数: 0 h-index: 0机构: Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, Japan Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, JapanTsuji, Yoshiro论文数: 0 引用数: 0 h-index: 0机构: Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, Japan Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, JapanHamaguchi, Kaori论文数: 0 引用数: 0 h-index: 0机构: Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, Japan Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, JapanYasunaga, Mai论文数: 0 引用数: 0 h-index: 0机构: Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, Japan Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, JapanOtsubo, Nobumasa论文数: 0 引用数: 0 h-index: 0机构: Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, Japan Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, JapanOnodera, Hideyuki论文数: 0 引用数: 0 h-index: 0机构: Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, Japan Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, JapanNishiya, Yoichi论文数: 0 引用数: 0 h-index: 0机构: Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, Japan Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, JapanSuzuki, Michihiko论文数: 0 引用数: 0 h-index: 0机构: Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, Japan Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, JapanSaito, Junichi论文数: 0 引用数: 0 h-index: 0机构: Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, Japan Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, JapanIshii, Toshihiko论文数: 0 引用数: 0 h-index: 0机构: Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, Japan Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, JapanNakai, Ryuichiro论文数: 0 引用数: 0 h-index: 0机构: Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, Japan Kyowa Hakko Kirin Co Ltd, Nagaizumi, Shizuoka, Japan
- [28] YAP1 Exerts Its Transcriptional Control via TEAD-Mediated Activation of EnhancersPLOS GENETICS, 2015, 11 (08):Stein, Claudia论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharma AG, Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, Switzerland Novartis Pharma AG, Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, SwitzerlandBardet, Anais Flore论文数: 0 引用数: 0 h-index: 0机构: Friedrich Miescher Inst Biomed Res, Basel, Switzerland Novartis Pharma AG, Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, SwitzerlandRoma, Guglielmo论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharma AG, Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, Switzerland Novartis Pharma AG, Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, SwitzerlandBergling, Sebastian论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharma AG, Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, Switzerland Novartis Pharma AG, Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, SwitzerlandClay, Ieuan论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharma AG, Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, Switzerland Novartis Pharma AG, Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, SwitzerlandRuchti, Alexandra论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharma AG, Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, Switzerland Novartis Pharma AG, Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, SwitzerlandAgarinis, Claudia论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharma AG, Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, Switzerland Novartis Pharma AG, Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, SwitzerlandSchmelzle, Tobias论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharma AG, Novartis Inst Biomed Res, Oncol, Basel, Switzerland Novartis Pharma AG, Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, SwitzerlandBouwmeester, Tewis论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharma AG, Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, Switzerland Novartis Pharma AG, Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, SwitzerlandSchuebeler, Dirk论文数: 0 引用数: 0 h-index: 0机构: Friedrich Miescher Inst Biomed Res, Basel, Switzerland Univ Basel, Fac Sci, Basel, Switzerland Novartis Pharma AG, Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, SwitzerlandBauer, Andreas论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharma AG, Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, Switzerland Novartis Pharma AG, Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, Switzerland
- [29] yap1b, a divergent Yap/Taz family member, cooperates with yap1 in survival and morphogenesis via common transcriptional targetsDEVELOPMENT, 2019, 146 (13):Vazquez-Marin, Javier论文数: 0 引用数: 0 h-index: 0机构: UPO, CSIC, Ctr Andaluz Biol Desarrollo, JA, Seville 41013, Spain UPO, CSIC, Ctr Andaluz Biol Desarrollo, JA, Seville 41013, SpainArturo Gutierrez-Triana, Jose论文数: 0 引用数: 0 h-index: 0机构: Heidelberg Univ, COS, D-69120 Heidelberg, Germany Univ Ind Santander, Fac Salud, Escuela Microbiol, Bucaramanga 680002, Colombia UPO, CSIC, Ctr Andaluz Biol Desarrollo, JA, Seville 41013, SpainAlmuedo-Castillo, Maria论文数: 0 引用数: 0 h-index: 0机构: UPO, CSIC, Ctr Andaluz Biol Desarrollo, JA, Seville 41013, Spain UPO, CSIC, Ctr Andaluz Biol Desarrollo, JA, Seville 41013, SpainBuono, Lorena论文数: 0 引用数: 0 h-index: 0机构: UPO, CSIC, Ctr Andaluz Biol Desarrollo, JA, Seville 41013, Spain UPO, CSIC, Ctr Andaluz Biol Desarrollo, JA, Seville 41013, SpainLuis Gomez-Skarmeta, Jose论文数: 0 引用数: 0 h-index: 0机构: UPO, CSIC, Ctr Andaluz Biol Desarrollo, JA, Seville 41013, Spain UPO, CSIC, Ctr Andaluz Biol Desarrollo, JA, Seville 41013, SpainLuis Mateo, Juan论文数: 0 引用数: 0 h-index: 0机构: Heidelberg Univ, COS, D-69120 Heidelberg, Germany Univ Oviedo, Dept Informat, Oviedo 33005, Spain UPO, CSIC, Ctr Andaluz Biol Desarrollo, JA, Seville 41013, SpainWittbrodt, Joachim论文数: 0 引用数: 0 h-index: 0机构: Heidelberg Univ, COS, D-69120 Heidelberg, Germany UPO, CSIC, Ctr Andaluz Biol Desarrollo, JA, Seville 41013, SpainRamon Martinez-Morales, Juan论文数: 0 引用数: 0 h-index: 0机构: UPO, CSIC, Ctr Andaluz Biol Desarrollo, JA, Seville 41013, Spain UPO, CSIC, Ctr Andaluz Biol Desarrollo, JA, Seville 41013, Spain
- [30] Structure-based discovery of a novel small-molecule inhibitor of TEAD palmitoylation with anticancer activityFRONTIERS IN ONCOLOGY, 2022, 12Gridnev, Artem论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Dallas, Dept Biol Sci, Richardson, TX 75080 USA Univ Texas Dallas, Dept Biol Sci, Richardson, TX 75080 USAMaity, Subhajit论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Dallas, Dept Biol Sci, Richardson, TX 75080 USA Univ Texas Dallas, Dept Biol Sci, Richardson, TX 75080 USAMisra, Jyoti R. R.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Dallas, Dept Biol Sci, Richardson, TX 75080 USA Univ Texas Dallas, Dept Biol Sci, Richardson, TX 75080 USA